NCT06820307View on ClinicalTrials.gov

Evaluation of the Effect of Suzetrigine (SUZ) on the Pharmacokinetics of Oral Contraceptives in Healthy Female Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 25, 2025

Primary Completion Date

April 29, 2025

Study Completion Date

April 29, 2025

Conditions
Pain
Interventions
DRUG

Suzetrigine

Tablets for Oral Administration.

DRUG

DRSP/EE

Combination Tablets for Oral Administration.

DRUG

NGM/EE

Combination Tablets for Oral Administration.

Trial Locations (1)

85283

Celerion - Tempe, Tempe

All Listed Sponsors
lead

Vertex Pharmaceuticals Incorporated

INDUSTRY